Description
The discussion centers on a 44-year-old man with a rapidly progressive, diagnostically elusive multifocal disease. Initially, a left L5 lesion was thought to be a benign multilobulated cyst or arachnoid/Tarlov cyst associated with a separate bone lesion, but further imaging suggested a more complex process with possible communication to the dura. MRI, CT myelogram, and repeat imaging were debated, including whether diffusion or delayed myelography might help distinguish CSF-containing cystic pathology from solid or gelatinous tumor. The patient had axial back pain without clear radicular symptoms and was initially considered for surgery or kyphoplasty, but the possibility of biopsy risk, CSF communication, and alternate diagnoses such as GCT or other tumor were discussed. One participant suggested surveillance and advanced MRI techniques rather than immediate biopsy.
The conversation then shifted to a second, more severe case: the same patient or another similarly ill 44-year-old man with a massive pericardial effusion, suspected adenocarcinoma cells in pericardial fluid, and widespread lesions involving the spine, pelvis, femora, and a large C7 lesion causing arm weakness and sensory symptoms. Myeloma workup and bone marrow biopsies were negative despite high suspicion, and an attempted CT-guided C7 biopsy was unsuccessful. Because tissue diagnosis could not be obtained and the patient was clinically deteriorating, palliative radiotherapy was started empirically for the C7 lesion. The speaker described a difficult surgical decompression and open biopsy of the C7 posterior elements with navigation and preoperative CT angiography, but the operation was complicated by the discovery of a massive saddle pulmonary embolism during surgery. The surgeon proceeded, obtained tissue, and later reflected on the absence of a drain and the risks of postoperative anticoagulation. The patient’s neurologic status temporarily worsened but then improved as sedation wore off.
Subsequent investigations suggested a possible primary in the heart or thigh, with differential diagnoses including synovial sarcoma, malignant peripheral nerve sheath tumor, or angiosarcoma, but repeated biopsies of the thigh and other sites were negative. Later imaging also showed a neck fluid collection/hematoma with elevated inflammatory markers and concern for infection, while the cardiac lesion was ultimately thought to be old blood rather than a resectable tumor. The speakers discussed how often aggressive cancers can be impossible to diagnose despite repeated biopsies, and whether to continue chasing tissue versus focusing on symptom control and palliation. They emphasized that in very sick patients with rapidly progressive disease, empiric radiotherapy or even broader palliative decisions may be reasonable when diagnosis cannot be secured and treatment is unlikely to change outcomes. The dialogue ends with reflection on the discomfort clinicians feel when there is no clear diagnosis, the family’s desire for closure, and the possibility that the patient’s course may represent a highly aggressive metastatic or sarcomatous process of unknown primary, though no definitive pathology was ever established.